Literature DB >> 28826529

Complement System in Neural Synapse Elimination in Development and Disease.

Jessy Presumey1, Allison R Bialas1, Michael C Carroll2.   

Abstract

Recent discoveries implicate the classical complement cascade in normal brain development and in disease. Complement proteins C1q, C3, and C4 participate in synapse elimination, tagging inappropriate synaptic connections between neurons for removal by phagocytic microglia that exist in a special, highly phagocytic state during the synaptic pruning period. Several neurodevelopmental disorders, such as schizophrenia and autism, are thought to be caused by an imbalance in synaptic pruning, and recent studies suggest that dysregulation of complement could promote this synaptic pruning imbalance. Moreover, in the mature brain, complement can be aberrantly activated in early stages of neurodegenerative diseases to stimulate synapse loss. Similar pathways can also be activated in response to inflammation, as in West Nile Virus infection or in lupus, where peripheral inflammation can promote microglia-mediated synapse loss. Whether synapse loss in disease is a true reactivation of developmental synaptic pruning programs remains unclear; nonetheless, complement proteins represent potential therapeutic targets for both neurodevelopmental and neurodegenerative diseases.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complement C4; Lupus; Microglia; Neurodegeneration; Schizophrenia; Synaptic pruning; Type I IFN

Mesh:

Substances:

Year:  2017        PMID: 28826529     DOI: 10.1016/bs.ai.2017.06.004

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  83 in total

1.  Back to the future - non-canonical functions of complement.

Authors:  Claudia Kemper; Jörg Köhl
Journal:  Semin Immunol       Date:  2018-06       Impact factor: 11.130

2.  Poster Viewing Sessions PB01-B01 to PB03-V09.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

3.  A proteomic signature associated to atypical antipsychotic response in schizophrenia patients: a pilot study.

Authors:  Daniel Martins-de-Souza; Paul C Guest; Johann Steiner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-04-01       Impact factor: 5.270

Review 4.  Fifty Years of Research on Schizophrenia: The Ascendance of the Glutamatergic Synapse.

Authors:  Joseph T Coyle; W Brad Ruzicka; Darrick T Balu
Journal:  Am J Psychiatry       Date:  2020-12-01       Impact factor: 18.112

Review 5.  Deciphering microbiome and neuroactive immune gene interactions in schizophrenia.

Authors:  Emily G Severance; Robert H Yolken
Journal:  Neurobiol Dis       Date:  2018-11-22       Impact factor: 5.996

Review 6.  Glial Cells Shape Pathology and Repair After Spinal Cord Injury.

Authors:  Andrew D Gaudet; Laura K Fonken
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

7.  Some Galeomorph Sharks Express a Mammalian Microglia-Specific Protein in Radial Ependymoglia of the Telencephalon.

Authors:  Skirmantas Janušonis
Journal:  Brain Behav Evol       Date:  2017-12-13       Impact factor: 1.808

8.  Intracellular C3 Protects Human Airway Epithelial Cells from Stress-associated Cell Death.

Authors:  Hrishikesh S Kulkarni; Michelle L Elvington; Yi-Chieh Perng; M Kathryn Liszewski; Derek E Byers; Christopher Farkouh; Roger D Yusen; Deborah J Lenschow; Steven L Brody; John P Atkinson
Journal:  Am J Respir Cell Mol Biol       Date:  2019-02       Impact factor: 6.914

Review 9.  Complement and the Regulation of T Cell Responses.

Authors:  Erin E West; Martin Kolev; Claudia Kemper
Journal:  Annu Rev Immunol       Date:  2018-04-26       Impact factor: 28.527

10.  Complement-Dependent Synaptic Uptake and Cognitive Decline after Stroke and Reperfusion Therapy.

Authors:  Ali M Alawieh; E Farris Langley; Wuwei Feng; Alejandro M Spiotta; Stephen Tomlinson
Journal:  J Neurosci       Date:  2020-04-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.